IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.

by Sewell, H. F., Thompson, W. D., King, D. J.
Published 1986

The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.

by Pedley, R. B., Boden, J. A., Boden, R., Begent, R. H., Turner, A., Haines, A. M., King, D. J.
Published 1994

Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.

by Turner, A., King, D. J., Farnsworth, A. P., Rhind, S. K., Pedley, R. B., Boden, J., Boden, R., Millican, T. A., Millar, K., Boyce, B.
Published 1994

Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.

by Casey, J. L., King, D. J., Pedley, R. B., Boden, J. A., Boden, R., Chaplin, L. C., Dorning, M., Begent, R. H.
Published 1998

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

by Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., King, D. J.
Published 1996

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.

by Casey, J. L., King, D. J., Chaplin, L. C., Haines, A. M., Pedley, R. B., Mountain, A., Yarranton, G. T., Begent, R. H.
Published 1996

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

by King, D. J., Antoniw, P., Owens, R. J., Adair, J. R., Haines, A. M., Farnsworth, A. P., Finney, H., Lawson, A. D., Lyons, A., Baker, T. S.
Published 1995